Project summary:

The MELODY (Mass evaluation of lateral flow immunoassays for the detection of SARS-CoV-2 antibody responses in immunosuppressed people) study is using home antibody testing to improve our understanding of responses to COVID-19 vaccination in individuals who are receiving immunosuppression.


Medical Research Council, Kidney Research UK, Vasculitis UK, Blood Cancer UK, Systic Fibrosis Trust.

Leader researcher:

Dr Michelle Willicombe

Lead institution:

Imperial College London

Recruitment for clinical trial open: